Despite their benefits, waivers are not without challenges. One primary concern is ensuring that the decision to grant a waiver does not compromise public safety. Regulatory agencies must carefully evaluate the merits of each waiver application to ensure that the absence of data does not lead to unforeseen health risks. Furthermore, inconsistencies in waiver policies across different jurisdictions can complicate the regulatory process for multinational companies.
